[
  {
    "page_number": 0,
    "bbox": [
      158.13,
      282.1,
      441.55,
      338.65
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      16.0
    ],
    "text": "PARLIAMENT OF THE DEMOCRATICSOCIALIST REPUBLIC OFSRI LANKA"
  },
  {
    "page_number": 0,
    "bbox": [
      207.57,
      576.67,
      392.13,
      585.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "PRINTED AT THE DEPARTMENT OF GOVERNMENT PRINTING, SRI LANKA"
  },
  {
    "page_number": 0,
    "bbox": [
      195.57,
      586.27,
      404.13,
      595.34
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      6.0,
      8.0
    ],
    "text": "TO BE PURCHASED AT THE GOVERNMENT PUBLICATIONS BUREAU, COLOMBO 5"
  },
  {
    "page_number": 0,
    "bbox": [
      143.85,
      609.89,
      455.83,
      621.23
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      10.0
    ],
    "text": "Price : Rs. 60.00Postage : Rs. 35.00"
  },
  {
    "page_number": 0,
    "bbox": [
      158.97,
      528.89,
      441.81,
      552.23
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "Published as a Supplement to Part II of the Gazette of the DemocraticSocialist Republic of Sri Lanka of November 25, 2022"
  },
  {
    "page_number": 0,
    "bbox": [
      143.61,
      659.95,
      344.59,
      669.02
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "This Act can be downloaded from www.documents.gov.lk"
  },
  {
    "page_number": 0,
    "bbox": [
      223.29,
      478.97,
      370.29,
      490.31
    ],
    "fonts": [
      "Times-Italic"
    ],
    "sizes": [
      10.0
    ],
    "text": "Printed on the Order of Government"
  },
  {
    "page_number": 0,
    "bbox": [
      219.21,
      452.93,
      380.49,
      464.27
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      10.0
    ],
    "text": "[Certified on 23rd of November, 2022]"
  },
  {
    "page_number": 0,
    "bbox": [
      171.57,
      379.95,
      428.0,
      407.96
    ],
    "fonts": [
      "Times-Bold",
      "TimesNewRomanPS-BoldMT"
    ],
    "sizes": [
      12.0
    ],
    "text": "POISONS, OPIUM AND DANGEROUS DRUGS(AMENDMENT) ACT, No. 41 OF 2022"
  },
  {
    "page_number": 1,
    "bbox": [
      186.09,
      166.97,
      384.65,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "1Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 1,
    "bbox": [
      143.85,
      227.33,
      206.85,
      238.67
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "L.D.O. 5/2021"
  },
  {
    "page_number": 1,
    "bbox": [
      156.81,
      250.73,
      357.93,
      273.83
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "AN ACT TO AMEND THE POISONS, OPIUM AND DANGEROUSDRUGS ORDINANCE (CHAPTER 218)"
  },
  {
    "page_number": 1,
    "bbox": [
      143.85,
      285.89,
      370.94,
      308.87
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "BE it enacted by the Parliament of the DemocraticSocialist Republic of Sri Lanka as follows:-"
  },
  {
    "page_number": 1,
    "bbox": [
      143.85,
      320.93,
      383.85,
      344.03
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "1. This Act may be cited as the Poisons, Opium andDangerous Drugs (Amendment) Act, No. 41 of 2022."
  },
  {
    "page_number": 1,
    "bbox": [
      143.85,
      356.09,
      383.87,
      390.83
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "2. Section 54A of the Poisons, Opium and DangerousDrugs Ordinance (Chapter 218) (hereinafter referred to asthe principal enactment) is hereby amended as follows: -"
  },
  {
    "page_number": 1,
    "bbox": [
      164.85,
      402.89,
      383.85,
      425.87
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "(1) by the re-numbering of section 54A as subsection(1) of that section;"
  },
  {
    "page_number": 1,
    "bbox": [
      164.85,
      437.93,
      383.88,
      472.67
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(2) in the renumbered subsection (1), by the repeal ofall the words from In this section: - to the end ofthat section;"
  },
  {
    "page_number": 1,
    "bbox": [
      164.85,
      484.73,
      383.86,
      507.83
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(3) by the insertion immediately after subsection (1),of the following new subsections: -"
  },
  {
    "page_number": 1,
    "bbox": [
      181.89,
      519.89,
      383.88,
      554.63
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(2) In any proceedings under subsection (1), acertificate signed by an authorized analystconfirming -"
  },
  {
    "page_number": 1,
    "bbox": [
      208.89,
      566.69,
      370.31,
      578.03
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(a) the type of the dangerous drug; and"
  },
  {
    "page_number": 1,
    "bbox": [
      208.89,
      590.09,
      383.87,
      613.07
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(b) that the gross weight of such dangerousdrug is two grammes or less,"
  },
  {
    "page_number": 1,
    "bbox": [
      180.81,
      625.13,
      383.89,
      671.75
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "shall be prima facie evidence of the facts statedtherein and the pure quantity of such dangerousdrug shall be deemed to be not exceeding twogrammes."
  },
  {
    "page_number": 1,
    "bbox": [
      395.85,
      322.51,
      430.3,
      331.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Short title"
  },
  {
    "page_number": 1,
    "bbox": [
      395.85,
      356.59,
      449.13,
      384.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "Amendment ofsection 54A ofChapter 218"
  },
  {
    "page_number": 1,
    "bbox": [
      185.85,
      203.45,
      343.31,
      214.79
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "[Certified on 23rd of November, 2022]"
  },
  {
    "page_number": 2,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "2Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 2,
    "bbox": [
      260.11,
      202.97,
      338.83,
      214.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(3) In this section -"
  },
  {
    "page_number": 2,
    "bbox": [
      291.19,
      226.97,
      451.19,
      358.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "Goverment Analyst means the personholding office as the GovermentAnalyst for the time being andincludes an Additional, Deputy,Senior Assistant or AssistantGovernment Analyst and anyperson appointed to act as theGovernment Analyst or anAdditional, Deputy, SeniorAssistant or Assistant GovernmentAnalyst;"
  },
  {
    "page_number": 2,
    "bbox": [
      291.19,
      370.97,
      451.18,
      430.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "manufacture in relation to a dangerousdrug includes any process ofproducing such drug and therefining or transformation of onedrug into another;"
  },
  {
    "page_number": 2,
    "bbox": [
      291.19,
      442.97,
      360.92,
      454.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "traffick means-"
  },
  {
    "page_number": 2,
    "bbox": [
      310.15,
      466.97,
      451.16,
      502.31
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(a)to sell, give, procure, store,administer, transport, send,deliver or distribute; or"
  },
  {
    "page_number": 2,
    "bbox": [
      310.15,
      514.97,
      451.17,
      538.31
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(b)to offer to do anythingspecified in paragraph (a).."
  },
  {
    "page_number": 2,
    "bbox": [
      211.15,
      550.97,
      451.17,
      574.31
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "3. Section 77A of the principal enactment is herebyamended as follows: -"
  },
  {
    "page_number": 2,
    "bbox": [
      229.87,
      586.97,
      451.17,
      622.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(1) by the repeal of subsections (2), (3) and (4) of thatsection and the substitution therefor of thefollowing: -"
  },
  {
    "page_number": 2,
    "bbox": [
      262.15,
      634.97,
      451.17,
      670.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(2) Where the Government Analyst hasmade an examination of any drug, substance,article or preparation submitted to him under"
  },
  {
    "page_number": 2,
    "bbox": [
      139.15,
      550.51,
      192.43,
      588.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "Amendment ofsection 77A ofthe principalenactment"
  },
  {
    "page_number": 3,
    "bbox": [
      186.09,
      166.97,
      384.65,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "3Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 3,
    "bbox": [
      194.85,
      202.97,
      386.58,
      334.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "subsection (1), he shall, within a period not exceeding twelve months from the date of such submission, send a report setting out the result of his examination to the Magistrate or any other competent court which has the jurisdiction to try an offence committed under Chapter III or Chapter V of this Ordinance, with copies to the police officer who submitted such drug, substance, article and preparation or any portion or sample for examination and to the Police Narcotics Bureau."
  },
  {
    "page_number": 3,
    "bbox": [
      194.85,
      346.97,
      386.43,
      406.31
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(3) A report submitted to the Magistrate or any other competent court under subsection (2) shall be prima facie evidence in any inquiry, trial or other proceeding conducted under this Ordinance."
  },
  {
    "page_number": 3,
    "bbox": [
      194.85,
      418.97,
      389.17,
      502.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(4) Where any person raises an issue in respect of the opinion of the Government Analyst specified in the report referred to in subsection (3) in any inquiry, trial or other proceeding, the burden of proving the fact that such report is inaccurate shall lie on the person who raises such issue.."
  },
  {
    "page_number": 3,
    "bbox": [
      159.57,
      514.97,
      383.88,
      538.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(2)by the addition immediately after subsection (4) ofthat section, of the following: -"
  },
  {
    "page_number": 3,
    "bbox": [
      194.85,
      550.97,
      383.89,
      670.31
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(5) (a) Where the Magistrate or the judgeof any competent court having the jurisdictionto try the offence committed under Chapter IIIor Chapter V, is of the opinion that such drug,substance, article or preparation would becomenecessary in evidence during the proceedingsbefore such court in respect of any offence, heshall order the Police Narcotics Bureau or anyperson authorized by the Magistrate or the Judgeof such competent court to photograph such"
  },
  {
    "page_number": 4,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "4Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 4,
    "bbox": [
      263.11,
      202.73,
      452.15,
      331.07
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "drug, substance, article or preparation, includingthe packages and seals, and to preserve thenecessary evidance including packages andseals and to order the Police Narcotics Bureauor any person authorized by the Magistrate orthe Judge of such competent court to destroythe same in the presence of the Registrar of suchcourt, the prosecuting Counsel or the PoliceOfficer who conducts the prosecution or hisrepresentative and the defence Counsel or hisrepresentative."
  },
  {
    "page_number": 4,
    "bbox": [
      263.11,
      343.13,
      452.14,
      436.43
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(b) The Police Narcotics Bureau or theperson authorized by the Magistrate or the judgeof the competent court, as the case may be, shalltake the photographs in terms of the order madeunder paragraph (a) and forward suchphotographs and the necessary evidenceincluding packages and seals forthwith to therelevant court."
  },
  {
    "page_number": 4,
    "bbox": [
      263.11,
      448.49,
      452.24,
      588.47
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(c) The Police Narcotics Bureau or anyperson authorized by the Magistrate or the judgeof such competent court shall under thesupervision of the Magistrate or the judge ofthe competent court, as the case may be, destroyor cause to be destroyed such drug, substance,article or preparation in compliance with theorder made by such Magistrate or the judge asthe case may be, under paragraph (a) within aperiod of two months of the date of such orderand shall forthwith submit a report relating tosuch destruction to the relevant court."
  },
  {
    "page_number": 4,
    "bbox": [
      263.11,
      600.53,
      452.15,
      670.79
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(6) The Minister assigned the subject ofJustice may, with the concurrence of the JudicialService Commission prescribe by regulation,the mechanism of disposal of such drug,substance, article or preparation specified insubsection (5).."
  },
  {
    "page_number": 5,
    "bbox": [
      186.09,
      166.97,
      384.65,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "5Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 5,
    "bbox": [
      144.81,
      203.33,
      384.93,
      227.27
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "4. Section 83 of the principal enactment is hereby repealedand the following section is substituted therefor:-"
  },
  {
    "page_number": 5,
    "bbox": [
      198.81,
      241.13,
      384.93,
      328.07
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "83. (1) Subject to the provisions ofsections 84, 85 and subsection (2) of thissection, a person suspected or accused of anoffence under sections 54A and 54B of thisOrdinance, shall not be released on bail by theHigh Court except in exceptionalcircumstances."
  },
  {
    "page_number": 5,
    "bbox": [
      198.81,
      341.93,
      384.83,
      391.07
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "(2) Notwithstanding the provisions ofsections 84 and 85, a person suspected oraccused of an offence under subsection (1) ofsection 54A and section 54B-"
  },
  {
    "page_number": 5,
    "bbox": [
      205.65,
      404.93,
      384.86,
      479.27
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "(a)of which the pure quantity of thedangerous drug, trafficked, imported,exported or possessed is ten grammes orabove in terms of the report issued bythe Government Analyst under section77A ; and"
  },
  {
    "page_number": 5,
    "bbox": [
      205.65,
      493.13,
      384.84,
      517.07
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(b)which is punishable with death or lifeimprisoment,"
  },
  {
    "page_number": 5,
    "bbox": [
      198.81,
      530.93,
      384.83,
      554.87
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "shall not be released on bail except by theCourt of Appeal in exceptional circumstances."
  },
  {
    "page_number": 5,
    "bbox": [
      198.81,
      568.73,
      384.83,
      605.27
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(3) For the purposes of this sectiondangerous drug means Morphine, Cocaine,Heroin and Methamphetamine.."
  },
  {
    "page_number": 5,
    "bbox": [
      144.81,
      619.13,
      384.85,
      668.27
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "5. The following new sections are hereby insertedimmediately after section 83 of the principal enactment,and shall have effect as sections 84, 85, 86 and 87 of thatenactment :-"
  },
  {
    "page_number": 5,
    "bbox": [
      143.85,
      203.11,
      455.14,
      307.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "Replacement ofsection 83 of theprincipalenactmentNo bail foran offenceunder sections54A and 54Bexcept inexceptionalcircumstances"
  },
  {
    "page_number": 5,
    "bbox": [
      395.85,
      619.15,
      454.29,
      666.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Insertion of newsections 84, 85,86 and 87 in theprincipalenactment"
  },
  {
    "page_number": 6,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "6Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 6,
    "bbox": [
      264.19,
      202.97,
      450.22,
      286.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "84. A suspect or an accused who has notbeen tried and has not been convicted andsentenced by a Court under the provisions ofsubsection (1) of section 54A and section 54B,shall not be detained in custody for a periodexceeding twelve months from the date of hisarrest."
  },
  {
    "page_number": 6,
    "bbox": [
      264.19,
      299.33,
      450.23,
      444.83
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "85. Notwithstanding the provisions ofsection 84, on application made in that behalfby the Attorney-General to the High Courtestablished under Article 105 or a High Courtestablished by Article 154P of the Constitutionsuch court may, for good and sufficient reasonsthat shall be recorded, order that a suspect oran accused who has not been tried and has notbeen convicted and sentenced by a Court underthe provisions of subsection (1) of section 54Aand section 54B, be detained in custody for aperiod in excess of twelve months:"
  },
  {
    "page_number": 6,
    "bbox": [
      264.19,
      457.85,
      450.22,
      505.79
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "Provided that, the period of detentionordered under this section, shall not in any caseexceed three months at a time and twenty fourmonths in the aggregate."
  },
  {
    "page_number": 6,
    "bbox": [
      264.19,
      518.93,
      450.21,
      603.47
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "86. (1) A person who is alleged to havecommitted an offence under section 52, section54 or paragraphs (b), (c) or (d) of subsection (1)of section 54A (in this section referred to as theoffender) shall not be liable for prosecutionfor an offence under the said provision in thefollowing circumstances: -"
  },
  {
    "page_number": 6,
    "bbox": [
      297.19,
      616.37,
      450.21,
      664.55
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(a)where the quantity of thedangerous drug involved in thecommission of the offence is lessthan one gramme;"
  },
  {
    "page_number": 6,
    "bbox": [
      211.15,
      203.11,
      253.87,
      269.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "No personto bedetained formore thantwelvemonths incustody"
  },
  {
    "page_number": 6,
    "bbox": [
      211.15,
      300.31,
      259.15,
      328.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Extension ofthe period ofdetention"
  },
  {
    "page_number": 6,
    "bbox": [
      211.15,
      520.99,
      257.6,
      587.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Voluntaryadmission tomedicaltreatment forde-addictionandrehabilitation"
  },
  {
    "page_number": 7,
    "bbox": [
      186.09,
      166.97,
      384.65,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "7Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 7,
    "bbox": [
      232.89,
      201.77,
      385.93,
      244.07
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(b)where such person seeks toundergo medical treatment forde-addiction and rehabilitation;and"
  },
  {
    "page_number": 7,
    "bbox": [
      232.89,
      253.25,
      385.92,
      285.23
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(c)where the Attorney-General hassanctioned the staying of theprosecution."
  },
  {
    "page_number": 7,
    "bbox": [
      199.89,
      294.53,
      385.93,
      357.35
    ],
    "fonts": [
      "Times-Bold",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(2) (a) The Officer-in- Charge of the relevantPolice Station, who conducts the investigationon the offender shall refer the offender to beexamined by a Government Medical Officer toobtain a medical report on the extent of thedrug dependency of such person."
  },
  {
    "page_number": 7,
    "bbox": [
      199.89,
      366.65,
      385.93,
      460.31
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(b) If the medical report obtained underparagraph (a) confirms that the offender is adrug dependent person, the Officer-in-Chargeof the Police Station shall refer such person toresidential or non-residential treatmentor rehabilitation in a Treatment andRehabilitation Centre designated in terms ofthe Drug Dependent Persons (Treatment andRehabilitation) Act, No. 54 of 2007."
  },
  {
    "page_number": 7,
    "bbox": [
      199.89,
      469.61,
      385.98,
      542.75
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "(3) Notwithstanding the precedingprovisions of this section, any offender whofails to complete the treatment referred to inparagraph (b) of subsection (2) shall be liableto be prosecuted under section 52, section 54or subsection (1) of section 54A, as the casemay be."
  },
  {
    "page_number": 7,
    "bbox": [
      199.89,
      551.93,
      385.93,
      667.43
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.0,
      10.0
    ],
    "text": "87. Any person under the age of eighteenyears who commits an offence punishable withdeath or life imprisonment under section 52,section 54, paragraphs (b), (c) and (d) ofsubsection (1) of section 54A and 54B shall notbe punished with death or life imprisonmentand shall only be liable for imprisonment for aterm not exceeding ten years with compulsoryrehabilitation and five years probation underthe Probation of Offenders Ordinance(Chapter 23).."
  },
  {
    "page_number": 7,
    "bbox": [
      143.85,
      552.55,
      191.13,
      609.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Probation foryoungoffendersundereighteenyears of age"
  },
  {
    "page_number": 8,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "8Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 8,
    "bbox": [
      139.15,
      203.11,
      193.88,
      250.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Amendment ofthe ThirdSchedule to theprincipalenactment"
  },
  {
    "page_number": 8,
    "bbox": [
      312.67,
      276.91,
      452.24,
      295.34
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "GROUP B(sections 48, 51 and 68)"
  },
  {
    "page_number": 8,
    "bbox": [
      212.11,
      304.87,
      452.12,
      323.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Drugs, substances, articles or preparations to which the provisions asto importation, exportation and wholesale and retail trade apply."
  },
  {
    "page_number": 8,
    "bbox": [
      315.67,
      332.71,
      348.71,
      341.78
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "SECTION 1"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      351.55,
      446.1,
      387.84
    ],
    "fonts": [
      "Calibri",
      "Calibri-Italic",
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "1 Acetorphine3-O-acetyltetrahydro-7-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine (derivativeof thebaine)"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      396.79,
      418.41,
      414.98
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "2 Acetyl-alpha-N-[1-(-methylphenethyl)-4-methylfentanylpiperidyl]acetanilide"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      423.67,
      435.67,
      441.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "3 AcetylfentanylN-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      445.51,
      431.12,
      463.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "4 Acetylmethadol3-acetoxy-6-dimethylamino-4,4-diphenylheptane"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      467.35,
      427.39,
      476.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "5 AcryloylfentanylN-phenyl-N-[1-(2- phenylethyl)"
  },
  {
    "page_number": 8,
    "bbox": [
      225.19,
      480.19,
      429.56,
      489.26
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(acrylfentanyl)piperidin-4-yl] prop- 2-enamide"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      497.11,
      431.84,
      532.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      7.949842929840088,
      8.0
    ],
    "text": "6 AlfentanilN-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      540.67,
      445.52,
      558.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "7 AH-79213,4-Dichloro-N-{[1-(dimethylamino)cyclohexyl] methyl}benzamide"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      562.51,
      418.41,
      580.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "8 Allylprodine3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine"
  },
  {
    "page_number": 8,
    "bbox": [
      217.39,
      584.35,
      425.12,
      602.3
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "9 Alphacetyl-3-acetoxy-6-dimethylamino-methadol4,4-diphenylheptane"
  },
  {
    "page_number": 8,
    "bbox": [
      212.23,
      606.07,
      428.85,
      624.02
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "10 Alphameprodine-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine"
  },
  {
    "page_number": 8,
    "bbox": [
      212.23,
      627.91,
      434.96,
      645.86
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "11 Alphamethadol-6-dimethylamino-4,4 diphenyl-3-heptanol"
  },
  {
    "page_number": 8,
    "bbox": [
      212.23,
      650.11,
      417.68,
      659.18
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "12 Alpha-N-[1-(-methylphenethyl)-4-"
  },
  {
    "page_number": 8,
    "bbox": [
      225.19,
      663.31,
      401.84,
      672.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Methylfentanylpiperidyl]propionanilide"
  },
  {
    "page_number": 8,
    "bbox": [
      212.11,
      202.97,
      452.16,
      226.31
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "6. The Third Schedule to the principal enactment is herebyamended as follows:-"
  },
  {
    "page_number": 8,
    "bbox": [
      230.11,
      238.97,
      452.13,
      262.31
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "(1) by the substitution, for Group B of Part I of thatSchedule, of the following:-"
  },
  {
    "page_number": 9,
    "bbox": [
      186.09,
      166.97,
      384.65,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "9Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      203.11,
      178.91,
      212.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "13 Alpha-"
  },
  {
    "page_number": 9,
    "bbox": [
      155.85,
      216.67,
      379.19,
      235.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "MethylthiofentanylN-[1-[1-methyl-2-(2 thienyl)ethyl]-4-piperidyl]propionanilide"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      239.59,
      345.35,
      258.14
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "14 Alphaprodine-1,3-dimethyl-4-phenyl-4-propionoxypiperidine"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      262.63,
      353.63,
      290.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "15 Anileridine1-p-aminophenethyl-4-phenylpiperidine-4-carboxylicacid ethyl ester"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      295.15,
      353.63,
      323.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "16 Benzethidine1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylicacid ethyl ester"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      327.67,
      310.9,
      336.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "17 Benzylmorphine3-benzylmorphine"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      341.11,
      352.78,
      359.66
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "18 Betacetylmethadol -3-acetoxy-6-dimethylamino-4,4-diphenylheptane"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      364.15,
      352.05,
      373.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "19 beta-HydroxyfentanylN-[1-( -hydroxyphenethyl)-4-"
  },
  {
    "page_number": 9,
    "bbox": [
      244.89,
      377.59,
      337.19,
      386.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "piperidyl] propionanilide"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      391.15,
      382.89,
      409.7
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "20 beta-Hydroxy-3-N - [ 1 - ( - h y d r o x y p h e n e t h y l ) - 3 -methylfentanylmethyl-4-piperidyl]propionanilide"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      414.07,
      356.62,
      432.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "21 Betameprodine-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      437.11,
      363.34,
      455.66
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "22 Betamethadol -6-dimethylamino-4,4-diphenyl-3-heptanol"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      460.15,
      342.34,
      478.7
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "23 Betaprodine -1,3-dimethyl-4-phenyl-4-propionoxypiperidine"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      487.15,
      367.91,
      536.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "24 Bezitramide1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine25 ButyrfentanylN-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      540.55,
      370.16,
      559.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "26 Cannabisthe flowering or fruiting tops of thecannabis plant (resin not extracted)"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      567.55,
      377.52,
      595.7
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "27 Cannabis Resin,the separated resin, crude or purified,Extracts andobtained from the cannabis plantTinctures"
  },
  {
    "page_number": 9,
    "bbox": [
      142.89,
      604.15,
      346.89,
      662.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "28 CarfentanilMethyl 1-(2-phenylethyl)-4-[phenyl (propanoyl) amino]piperidine- 4- carboxylate29 Clonitazene2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole"
  },
  {
    "page_number": 10,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "10Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      202.87,
      451.16,
      239.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "30 Coca leafthe leaf of the coca bush (plant material),except a leaf from which all ecgonine,cocaine and any other ecgoninealkaloids have been removed"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      248.35,
      432.45,
      315.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "31 Cocainemethyl ester of benzoylecgonine(an alkaloid found in coca leavesor prepared by synthesis fromecgonine)32 Codoximedihydrocodeinone-6-carboxymethyloxime (derivate ofmorphine)"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      324.19,
      437.74,
      401.06
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "33 Concentrate ofThe material arising when parts ofpoppy strawany plant of the speciesPapaversomniferum have entered aprocess for the concentration of thealkaloids34 CyclopropylfentanylN-Phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]cyclopropanecarboxamide"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      405.43,
      402.44,
      423.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "35 DesomorphineDihydrodesoxymorphine(derivative of morphine)"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      432.19,
      439.16,
      490.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "36 Dextromoramide(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl) butyl]morpholine (dextro-rotatory isomerof moramide)37 DiampromideN-[2-(methylphenethylamino)-propyl] propionanilide"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      494.59,
      409.17,
      513.02
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "38 Diethylthiambutene3-diethylamino-1,1-di-(2-thienyl)-1-butene"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      517.39,
      431.59,
      535.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "39 Difenoxin1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      544.27,
      416.59,
      592.94
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "40 Dihydroetorphine7,8-dihydro-7-[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine(derivative of etorphine)41 Dihydromorphine(derivative of morphine)"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      597.31,
      430.16,
      615.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "42 Dimenoxadol2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      620.11,
      433.88,
      638.54
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "43 Dimepheptanol6-dimethylamino-4,4-diphenyl-3-heptanol"
  },
  {
    "page_number": 10,
    "bbox": [
      214.15,
      642.91,
      446.61,
      661.34
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "44 Dimethylthiambutene3-dimethylamino-1,1-di-(2-thienyl)-1-butene"
  },
  {
    "page_number": 11,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "11Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      202.99,
      330.58,
      221.54
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "45 Dioxaphetylethyl-4-morpholino-2,2-butyratediphenylbutyrate"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      225.79,
      380.85,
      265.1
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "46 Diphenoxylate1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acidethyl ester47 Dipipanone4,4-diphenyl-6-piperidine-3-heptanone"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      269.47,
      344.85,
      287.9
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "48 Drotebanol3,4-dimethoxy-17-methylmorphinan-6 ,14-diol"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      292.27,
      364.3,
      320.06
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "49 Ecgonineits esters and derivatives which areconvertible to ecgonine andcocaine"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      324.43,
      356.15,
      342.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "50 Ethylmethylthiambutene 3-ethylmethylamino-1,1-di-(2-thienyl)-1-butene"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      347.23,
      332.87,
      375.14
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "51 Etonitazene1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      383.47,
      364.29,
      450.86
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "52 Etorphinetetrahydro-7-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine (derivative ofthebaine)53 Etoxeridine1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylicacid ethyl ester"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      455.23,
      338.87,
      473.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "54 Fentanyl1-phenethyl-4-N-propionylanilinopiperidine"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      481.99,
      377.14,
      530.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "55 4-Fluoroisobutyrfentanyl N-(4-fluorophenyl)-N-(1-(4- FIBF, pFIBF)phenetylpiperidin-4-yl)isobutyramide56 FuranylfentanylN-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      538.99,
      365.87,
      578.3
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "57 Furethidine1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acidethyl ester58 HeroinDiacetylmorphine"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      582.55,
      309.57,
      591.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "59 HydrocodoneDihydrocodeinone"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      595.99,
      348.57,
      614.42
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "60 Hydromorphinol14-hydroxydihydromorphine(derivative of morphine)"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      618.79,
      365.18,
      637.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "61 Hydromorphonedihydromorphinone (derivative ofmorphine)"
  },
  {
    "page_number": 11,
    "bbox": [
      143.85,
      641.59,
      351.59,
      669.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "62 Hydroxypethidine4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylicacid ethyl ester"
  },
  {
    "page_number": 12,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "12Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      203.11,
      427.18,
      221.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "63 Isomethadone6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      226.39,
      430.87,
      245.06
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "64 Ketobemidone4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      249.55,
      376.88,
      268.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "65 Levomethorphan(-)-3-methoxy-N-methylmorphinan"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      272.59,
      421.89,
      300.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "66 Levomoramide(-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      305.11,
      390.44,
      323.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "67 Levophenacylmorphan(-)-3-hydroxy-N-phenacylmorphinan"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      328.15,
      376.88,
      346.7
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "68 Levorphanol(-)-3-hydroxy-N-methylmorphinan"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      351.07,
      425.6,
      369.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "69 Metazocine2-hydroxy-2,5,9-trimethyl-6,7-benzomorphan"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      374.11,
      433.88,
      392.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "70 Methadone6-dimethylamino-4,4-diphenyl-3-heptanone"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      397.15,
      424.17,
      415.7
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "71 Methadone4-cyano-2-dimethylamino-4,4-Intermediatediphenylbutane"
  },
  {
    "page_number": 12,
    "bbox": [
      211.15,
      420.07,
      421.99,
      448.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "72Methoxyacetyl2-Methoxy-N-phenyl-N-[1-(2-fentanylphenylethyl)piperidin-4-yl]acetamide"
  },
  {
    "page_number": 12,
    "bbox": [
      211.15,
      451.95,
      415.16,
      474.86
    ],
    "fonts": [
      "Cambria",
      "Times-Roman"
    ],
    "sizes": [
      8.0,
      11.0
    ],
    "text": "73Methyldesorphine6-methyl- -deoxymorphine(derivative of morphine)"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      479.35,
      407.59,
      497.9
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "74 Methyldihyd6-methyldihydromorphineromorphine (derivative of morphine)"
  },
  {
    "page_number": 12,
    "bbox": [
      211.15,
      502.27,
      413.73,
      520.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "753-MethylfentanylN-(3-methyl-1-phenethyl-4-piperidyl)propionanilide"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      525.31,
      400.88,
      553.34
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "76 3-MethylthioN-[3-methyl-1-[2-(2-fentanylthienyl) ethyl]-4-piperidyl]propionanilide"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      557.83,
      417.44,
      576.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "77 Metopon5-methyldihydromorphinone(derivative of morphine)"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      580.75,
      433.15,
      608.9
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "78 Moramide2-methyl-3-Intermediatemorpholino-1,1-diphenylpropanecarboxylic acid"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      613.27,
      421.89,
      641.42
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "79 Morpheridine1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylicacid ethyl ester"
  },
  {
    "page_number": 12,
    "bbox": [
      214.15,
      645.79,
      422.59,
      664.34
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "80 Morphinethe principal alkaloid of opiumand of opium poppy"
  },
  {
    "page_number": 12,
    "bbox": [
      347.11,
      456.0,
      357.67,
      464.0
    ],
    "fonts": [
      "BaaminiPlain",
      "Webdings"
    ],
    "sizes": [
      4.699999809265137,
      8.0
    ],
    "text": "6"
  },
  {
    "page_number": 13,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "13Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      203.11,
      361.29,
      261.86
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "81 Morphineany other pentavalentMethobromidenitrogen morphinederivativesincluding in particular themorphine-N-oxide derivatives,one of which is codeine-N-oxide82 Morphine-N-oxideA derivate of morphine"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      266.23,
      362.86,
      284.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "83 MPPP1-methyl-4-phenyl-4-piperidinolpropionate (ester)"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      289.03,
      373.3,
      307.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "84 MT-451-cyclohexyl-4-(1,2-diphenylethyl)piperazine"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      311.83,
      333.58,
      320.9
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "85 MyrophineMyristylbenzylmorphine"
  },
  {
    "page_number": 13,
    "bbox": [
      245.85,
      325.27,
      326.84,
      334.34
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(derivate of morphine)"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      338.59,
      332.86,
      357.14
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "86 Nicomorphine3,6-dinicotinylmorphine(derivate of morphine)"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      361.51,
      363.58,
      380.06
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "87 Noracymethadol()--3-acetoxy-6-methylamino-4,4-diphenylheptane"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      384.43,
      335.13,
      393.5
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "88 Norlevorphanol(-)-3-hydroxymorphinan"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      397.87,
      366.6,
      416.3
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "89 Normethadone6-dimethylamino-4,4-diphenyl-3-hexanone"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      420.55,
      327.58,
      439.1
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "90 Normorphinedemethylmorphine(derivate of morphine)"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      443.35,
      350.14,
      461.9
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "91 Norpipanone4,4-diphenyl-6-piperidino-3-hexanone"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      466.15,
      363.59,
      494.06
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "92 OcfentanilN-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      498.43,
      366.57,
      526.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "93 OpiumThe coagulated juice of the opiumpoppy plant speciesPapaversomniferum L."
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      530.59,
      325.42,
      539.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "94 Oripavine3-O-demethylthebaine"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      544.03,
      365.87,
      571.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "95 OrthofluorofentanylN-(2-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      576.19,
      353.86,
      594.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "96 Oxycodone14-hydroxydihydrocodeinone(derivate of morphine)"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      598.99,
      360.58,
      617.42
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "97 Oxymorphone14-hydroxydihydromorphinone(derivate of morphine)"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      621.79,
      360.59,
      649.7
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "98 ParafluorobutyrylN-(4-Fluorophenyl)-N-fentanyl[1-(2-phenylethyl)piperidin-4-yl]butanamide"
  },
  {
    "page_number": 13,
    "bbox": [
      146.85,
      653.95,
      347.13,
      672.5
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "99 para-Fluorofentanyl4-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide"
  },
  {
    "page_number": 14,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "14Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      202.87,
      404.13,
      221.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "100 PEPAP1-phenethyl-4-phenyl-4-piperidinol acetate (ester)"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      225.31,
      428.12,
      243.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "101 Pethidine1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      247.75,
      389.12,
      265.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "102 Pethidine4-cyano-1-methyl-4-Intermediate Aphenylpiperidine"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      270.07,
      392.85,
      297.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "103 Pethidine4-phenylpiperidine-4-Intermediate Bcarboxylic acid ethylester"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      301.75,
      417.57,
      319.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "104 Pethidine1-methyl-4-phenylpiperidineIntermediate C-4-carboxylic acid"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      324.07,
      423.57,
      342.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "105 Phenadoxone6-morpholino-4,4-diphenyl-3-heptanone"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      346.51,
      423.58,
      364.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "106 PhenampromideN-(1-methyl-2-piperidinoethyl)propionanilide"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      368.95,
      420.55,
      387.14
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "107 Phenazocine2-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      391.27,
      388.4,
      409.58
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "108 Phenomorphan3-hydroxy-N-phenethylmorphinan"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      413.71,
      435.56,
      441.14
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "109 Phenoperidine1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylicacid ethyl ester"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      445.27,
      434.12,
      472.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "110 Piminodine4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      480.91,
      432.55,
      528.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "111 Piritramide1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide112 Proheptazine1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      532.87,
      428.12,
      551.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "113 Properidine1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      553.27,
      378.67,
      573.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "114 Racemethorphan4()-3-methoxy-N-methylmorphinan"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      577.75,
      422.85,
      605.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "115 Racemoramide()-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      607.27,
      377.84,
      627.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "116 Racemorphan4()-3-hydroxy-N-methylmorphinan"
  },
  {
    "page_number": 14,
    "bbox": [
      212.23,
      635.71,
      422.16,
      672.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "117 Remifentanil1-(2-methoxycarbonylethyl)-4-(phenylpropionylamino)-piperidine-4-carboxylic acidmethyl ester"
  },
  {
    "page_number": 15,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "15Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      203.35,
      360.1,
      231.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "118 SufentanilN-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      236.71,
      368.38,
      265.34
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "119 TetrahydrofuranylN-phenyl-N-[1-fentanyl (THF-F) (2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2- carboxamide"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      270.07,
      334.54,
      298.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "120 ThebaconAcetyldihydrocodeinone(acetylated enol form ofhydrocodone)"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      303.55,
      361.55,
      332.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "121 Thebaine3,6-dimethoxy-17-methyl-6,7,8,14-tetradehydro-4,5alpha-epoxymorphinan"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      336.91,
      346.65,
      355.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "122 ThiofentanylN-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      360.55,
      366.82,
      389.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "123 Tilidine()-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      393.91,
      346.54,
      412.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "124 Trimeperidine1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      417.55,
      369.82,
      436.34
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "125 U-477003,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      442.15,
      367.55,
      480.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "126 Tramadol2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol127 Pregabalin(3S)-3-(aminomethyl)-5-methylhexanoic acid"
  },
  {
    "page_number": 15,
    "bbox": [
      144.93,
      486.31,
      382.54,
      505.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "128 Gabapentine2-[1-(Aminomethyl)cyclohexyl]aceticacid"
  },
  {
    "page_number": 15,
    "bbox": [
      144.81,
      510.91,
      384.82,
      539.54
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "1.The isomers, unless specifically excepted, of the dangerous drugsin this Section whenever the existence of such isomers is possiblewithin the specific chemical designation."
  },
  {
    "page_number": 15,
    "bbox": [
      144.81,
      550.27,
      384.8,
      579.02
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "2.The esters and ethers, unless appearing in another part, of thedangerous drugs in this Section whenever the existence of suchesters or ethers is possible."
  },
  {
    "page_number": 15,
    "bbox": [
      144.81,
      589.75,
      384.85,
      618.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "3.The salts of the dangerous drugs mentioned in this Section,including the salts of the isomers, whenever the formation ofsuch salts is possible."
  },
  {
    "page_number": 15,
    "bbox": [
      144.81,
      629.11,
      384.84,
      657.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "4.Any substance, that are substantially similar to the parentsubstances listed in this Section, which typically exhibiting highabuse potential."
  },
  {
    "page_number": 16,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "16Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 16,
    "bbox": [
      211.15,
      202.87,
      451.19,
      239.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "5.Any chemical analogue with modification in any of the atom ofthe parent substance listed in this Section by any atom or specificgroup of atoms (functional group), which typically exhibitinghigh abuse potential."
  },
  {
    "page_number": 16,
    "bbox": [
      211.15,
      249.19,
      451.2,
      276.5
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "6.Substances, preparations or mixtures containing any proportionof a dangerous drug in this Section and isomers, esters and saltsas specified in the paragraph 1, 2, 3, 4 and 5 above."
  },
  {
    "page_number": 16,
    "bbox": [
      211.15,
      286.51,
      451.18,
      341.06
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "7.Any solution or dilution of morphine or cocaine or their salts inan inert substance whether liquid or solid containing anyproportion of morphine or cocaine and any preparation,admixture, extracts, or other substances (not being such a solutionor dilution as aforesaid) containing not less than 0.2 per centumof morphine or 0.1 per centum of cocaine or ecgonine."
  },
  {
    "page_number": 16,
    "bbox": [
      319.15,
      350.23,
      352.19,
      359.3
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "SECTION 2"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      364.27,
      425.0,
      402.74
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "1 Cannabinol and6,6,9-Trimethyl-3-cannabinolpentyl-benzo[c]chromen-1-olderivatives (CBN)2 Cathinone()-(S)-2-aminopropiophenone"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      406.75,
      427.17,
      415.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "3 DET3-[2-(diethylamino)ethyl]indole"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      423.79,
      433.88,
      462.14
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      7.949842929840088,
      8.0
    ],
    "text": "4 DMHP3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran- 1-ol5 DMT3-[2-(dimethylamino)ethyl]indole"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      466.15,
      394.17,
      493.46
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "6 DMA()-2,5-dimethoxy--(2,5-Dimethoxymethylphenethylamineamphetamine)"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      506.59,
      419.61,
      524.78
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "7 DOET()-4-ethyl-2,5-dimethoxy--methylphenethylamine"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      528.79,
      394.17,
      556.1
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "8 DOB()-4-bromo-2,5-(Brolamfetamine)dimethoxy--methylphenethylamine"
  },
  {
    "page_number": 16,
    "bbox": [
      219.43,
      560.11,
      392.6,
      578.3
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "9 DOC4-Chloro-2,5-dimethoxyamfetamine"
  },
  {
    "page_number": 16,
    "bbox": [
      214.15,
      582.31,
      397.16,
      591.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "10 Etryptamine3-(2-aminobutyl)indole"
  },
  {
    "page_number": 16,
    "bbox": [
      211.15,
      600.55,
      427.17,
      645.98
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "11(+)-Lysergide andN,N-Diethyl-D-lysergamide andother substancesother substances structurallystructurallyderived from lysergamide byderived fromsubstitution of any of the atoms,lysergamide"
  },
  {
    "page_number": 16,
    "bbox": [
      214.15,
      657.07,
      430.16,
      666.14
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "12 Mescaline3,4,5-trimethoxyphenethylamine"
  },
  {
    "page_number": 17,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "17Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      203.11,
      324.1,
      260.78
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "13 MDMA(3,4-Methyl()-N,-dimethyl-3,4-enedioxymeth(methylenedioxy)amphetamine)phenethylamine14 5-Methoxy-MDA5-methoxy--methyl-(MMDA)3,4- (methylenedioxy)phenethylamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      265.27,
      307.54,
      293.06
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "15 Tenamfetamine-methyl-3,4-(MDA)(methylenedioxy)phenethylamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      297.31,
      345.1,
      315.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "16 4-Methylaminorex()-cis-2-amino-4-methyl-5-phenyl-2-oxazoline"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      319.87,
      367.55,
      338.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "17 Methcathinone2-(methylamino)-1-phenylpropan-1-one"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      342.67,
      339.14,
      370.46
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "18 4-Methylthio-methyl-4-amphetaminemethylthiophenethylamine(4-MTA)"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      374.83,
      324.1,
      402.62
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "19 N-Ethyl MDA()-N-ethyl--methyl-(MDEA)3,4- (methylenedioxy)phenethylamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      407.11,
      336.09,
      434.78
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "20 N-Hydroxy MDA()-N[-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      439.03,
      369.11,
      457.46
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "21 25B-NBOMe2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      461.71,
      368.27,
      480.02
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "22 25C-NBOMe2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      484.27,
      366.11,
      502.58
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "23 25I-NBOMe2-(4-iodo-2,5-dimethoxyphenyl)-N- (2-methoxybenzyl) ethanamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      506.83,
      369.1,
      534.5
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "24 Parahexyl3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      538.75,
      328.55,
      557.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "25 Eticyclidine (PCE)N-ethyl-1-phenylcyclohexylamine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      561.31,
      328.54,
      579.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "26 Rolicyclidine1-(1-phenylcyclohexyl)(PCPy)pyrrolidine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      583.99,
      362.26,
      602.3
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "27 Psilocine (psilotsin,3-[2-4-HO-DMT)(dimethylamino) ethyl]indol-4-ol"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      606.55,
      363.83,
      624.98
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "28 Psilocybine3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      629.11,
      362.26,
      647.54
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "29 p-Methoxyam1-(4-phetamine (PMA)methoxyphenyl) propan-2-amine"
  },
  {
    "page_number": 17,
    "bbox": [
      144.81,
      652.75,
      331.53,
      671.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "30 p-Methoxymetham1-(4-methoxyphenyl)-2-phetamine (PMMA)methylaminopropane"
  },
  {
    "page_number": 18,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "18Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      203.11,
      413.13,
      253.7
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "31 2,5-Dimethoxy-4-2,5-dimethoxy-,4-methylamphetaminedimethylphenethylamine(STP, DOM)32 Tenocyclidine (TCP)1-[1-(2-thienyl)cyclohexyl]piperidine"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      258.31,
      423.69,
      286.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "33 Tetrahydro-tetrahydrocannabinol,cannabinol (THC)the following isomers and theirstereochemical variants:"
  },
  {
    "page_number": 18,
    "bbox": [
      230.11,
      291.07,
      408.56,
      319.34
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(i) delta-6a(10a)-THC 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol"
  },
  {
    "page_number": 18,
    "bbox": [
      230.11,
      323.83,
      430.39,
      352.1
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(ii) delta-6a(7)-THC(9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran- 1-ol"
  },
  {
    "page_number": 18,
    "bbox": [
      230.11,
      356.71,
      437.11,
      384.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(iii) delta-7-THC(6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol"
  },
  {
    "page_number": 18,
    "bbox": [
      230.11,
      389.47,
      437.96,
      417.74
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(iv) delta-8-THC(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol"
  },
  {
    "page_number": 18,
    "bbox": [
      230.11,
      422.23,
      407.83,
      450.5
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(v) delta-10-THC6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      455.11,
      412.38,
      514.34
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(vi) delta-9(11)-THC(6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene3-pentyl-6H-dibenzo[b,d]pyran-1-ol34 Trimethoxyam()-3,4,5-trimethoxy--phetamine (TMA)methylphenethylamine"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      518.83,
      416.85,
      527.9
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "35 Amphetamine()--methylphenethylamine"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      532.51,
      413.96,
      560.78
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "36 Amineptine7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      565.27,
      430.39,
      583.94
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "37 AM-2201,[1-(5-Fluoropentyl)-1H-indol-3-JWH-2201yl](naphthalen-1-yl)methanone"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      588.43,
      429.54,
      616.7
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "38 5F-APINACA,N-(adamantan-1-yl)-1-5F-AKB-48(5-fluoropentyl)-1H-indazole-3-carboxamide"
  },
  {
    "page_number": 18,
    "bbox": [
      215.11,
      625.27,
      392.83,
      663.14
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "39 5F-AMB, 5F-AMBMethyl 2-({[1-(5--PINACAfluoropentyl)-1H-indazol-3yl]carbonyl}amino)-3-methylbutanoate"
  },
  {
    "page_number": 19,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "19Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      203.11,
      338.27,
      221.54
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "40 2C-B4-bromo-2,5-dimethoxyphenethylamine"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      228.55,
      365.27,
      294.14
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "41 AB-CHMINACAN-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide42 CUMYL-4CN-1-(4-cyanobutyl)-N-(2-BINACAphenylpropan-2-yl)-1H-indazole-3-carboxamide"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      302.23,
      330.1,
      338.54
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "43 ADB-CHMINACA,N-[(2S)-1- amino-3,3-MAB-CHMINACAdimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      343.63,
      346.55,
      391.46
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "44 4-Chlorome1-(4-chlorophenyl)-2-thcathinone,(methylamino)-1-propanoneClephedrone(4-CMC)45 dexamphetamine(+)--methylphenethylamine"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      400.75,
      347.25,
      446.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "46 Dronabinol (delta(6aR,10aR)-6a,7,8,10a--9-tetrahydro-6,6,9- trimethyl-3- pentyl-6H-cannabinol and itsdibenzo[b,d]pyran-1-olstereochemicalvariants)"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      457.27,
      364.53,
      475.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "47 Ethylone(RS)-1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      479.47,
      349.66,
      497.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "48 Ethylphenidateethyl 2-phenyl-2-piperidin-2-ylacetate [1]"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      501.67,
      339.94,
      519.86
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "49 Fenetylline7-[2-[(-methylphenethyl)amino]ethyl]theophylline"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      523.87,
      313.54,
      542.06
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "50 4-Fluoroam1-(4-Fluorophenyl)phetamine, 4-FApropan-2-amine"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      550.15,
      364.53,
      586.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "51 FUB-AMB, MMB-Methyl(2S)-2-({1-[4-fluorophenyl]FUBINACA, AMB- methyl-1H- indazole-3FUBINACA-carbonyl}amino)-3-methylbutanoate"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      591.55,
      363.82,
      627.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "52 ADB-FUBINACAN-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide"
  },
  {
    "page_number": 19,
    "bbox": [
      144.81,
      632.95,
      361.55,
      669.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "53 AB-FUBINACAN-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide"
  },
  {
    "page_number": 20,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "20Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      203.35,
      394.16,
      222.14
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "54 -Hydroxybutyric-Hydroxybutyric acidacid (GHB ACID)"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      226.87,
      424.89,
      245.78
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "55 JWH-018, AM-678Naphthalene-1-yl(1-pentyl-1H-indol-3-yl)methanone"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      250.51,
      417.43,
      269.42
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "56 Ketamine2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      274.15,
      431.0,
      292.94
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "57 Levamphetamine()-(R)--methylphenethylamine(amphetamine(-) isomer"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      297.67,
      430.17,
      316.58
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "58 Levometham()-N,-dimethylphenethylaminephetamine"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      321.31,
      420.32,
      340.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "59 Mecloqualone3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      348.91,
      400.88,
      379.58
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "60 Methamphetamine(+)-(S)-N,-(Methylamphetamine)dimethylphenethylamine61 Methaqualone"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      394.15,
      289.12,
      403.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "62 Methylphenidate"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      417.67,
      295.16,
      436.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "63 Methamphetamine racemate"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      445.27,
      298.88,
      454.34
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "64 3,4-Methylenedioxy"
  },
  {
    "page_number": 20,
    "bbox": [
      313.12,
      370.51,
      406.86,
      389.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "2-methyl-3-o-tolyl-4(3H)-quinazolinone"
  },
  {
    "page_number": 20,
    "bbox": [
      313.15,
      394.1,
      421.45,
      412.87
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "methyl -phenyl-2-piperidine acetate"
  },
  {
    "page_number": 20,
    "bbox": [
      313.15,
      417.6,
      430.16,
      426.67
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "()-N,-dimethylphenethylamine"
  },
  {
    "page_number": 20,
    "bbox": [
      229.15,
      445.2,
      427.87,
      474.02
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(RS)-1-(Benzo[d][1,3]dioxol-5-pyrovalerone(MDPV)yl)-2- (pyrrolidin-1-yl)pentan-1-one"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      479.71,
      428.59,
      529.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "65 Mephedrone, 4-(RS)-2-methylamino-1-(4-methylmethcathinonemethylphenyl)propan-1-one66 Methylone,(RS)-2-methylamino-1-(3,4-(beta-keto-MDMA)methylenedioxyphenyl) propan-1-one"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      534.67,
      420.44,
      553.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "67 Methoxetamine(RS)-2-(3-methoxyphenyl)-2-(MXE)(ethylamino)-cyclohexanone"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      558.31,
      426.45,
      586.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "68 MDMB-CHMICAmethyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3dimethylbutanoate"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      591.67,
      388.88,
      610.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "69 Methiopropamine1-(thiophen-2-yl)-2-(MPA)methylaminopropane"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      615.31,
      416.61,
      634.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "70 4-methylethcathinone2-(Ethylamino)-1-(4- (4-MEC)methylphenyl) propan-1-one"
  },
  {
    "page_number": 20,
    "bbox": [
      214.15,
      642.91,
      424.16,
      671.54
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "71 5F-MDMB-PICAMethyl(S)-2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate"
  },
  {
    "page_number": 21,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "21Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      203.11,
      359.86,
      254.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "72 4F-MDMB-BINACAMethyl(S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate73 N-Benzylpiperazine1-benzylpiperazine(BZP)"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      259.15,
      357.58,
      277.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "74 N-Ethylnorpentylone1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      282.31,
      344.15,
      300.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "75 N-Ethylhexedrone2-(Ethylamino)-1-phenyl-1-hexanone"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      305.59,
      327.58,
      324.26
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "76 Phencyclidine (PCP)1-(1-phenylcyclohexyl)piperidine"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      328.75,
      351.59,
      337.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "77 Phenmetrazine3-methyl-2-phenylmorpholine"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      346.39,
      351.58,
      414.98
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "78 5F-ADB, 5F-MDMBMethyl(2S)-2-{[1--PINACA(fluoropentyl)-1H-indazole-3-carbonyl] amino}-3,3-dimethylbutanoate79 AB-PINACAN-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      419.71,
      344.86,
      428.78
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "80 alpha-PVP-pyrrolidinovalerophenone"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      433.39,
      308.87,
      452.06
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "81 4,4-dimethylaminorex para-methyl-(4,4-DMAR)4-methylaminorex"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      456.55,
      327.58,
      475.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "82 Pentedrone()-2-(methylamino)-1-phenylpentan-1-one"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      479.71,
      362.85,
      498.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "83 5F-PB-22Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      502.99,
      358.3,
      521.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "84 alpha-PHP(RS)-1-Phenyl-2-(pyrrolidine-1-yl)hexan-1-one"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      526.15,
      339.59,
      544.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "85 Secobarbital5-allyl-5-(1-methylbutyl)barbituric acid"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      549.31,
      362.86,
      577.58
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "86 UR-144(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropoyl)methanone"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      582.19,
      358.28,
      610.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "87 XLR-11[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3tetramethylcyclopropyl)methanone"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      615.07,
      342.59,
      643.46
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "88 Zipeprol-(-methoxybenzyl)-4-(-methoxyphenethyl)-1-piperazineethanol"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      647.95,
      362.13,
      657.02
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "89 Amobarbital5-ethyl-5-isopentylbarbituric acid"
  },
  {
    "page_number": 21,
    "bbox": [
      143.85,
      661.51,
      356.14,
      670.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "90 Butalbital5-allyl-5-isobutylbarbituric acid"
  },
  {
    "page_number": 22,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "22Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 22,
    "bbox": [
      215.11,
      203.11,
      422.94,
      260.42
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "91 Buprenorphine2l-cyclopropyl-7--[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano- 6,7,8,14-tetrahydrooripavine92 Cyclobarbital5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid"
  },
  {
    "page_number": 22,
    "bbox": [
      215.11,
      268.51,
      438.68,
      327.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "93 (+)-Norpseudoe2-amino-1-hydroxy-1phedrine-phenylpropane(including Cathine)94 Flunitrazepam5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 22,
    "bbox": [
      215.11,
      331.75,
      415.41,
      340.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "95 Glutethimide2-ethyl-2-phenylglutarimide"
  },
  {
    "page_number": 22,
    "bbox": [
      215.11,
      344.95,
      410.85,
      363.14
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "96 Pentobarbital5-ethyl-5-(1-methylbutyl)barbituric acid"
  },
  {
    "page_number": 22,
    "bbox": [
      215.11,
      371.35,
      428.84,
      419.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "97 Pentazocine(2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6- methano-3-benzazocin-8-ol98 diethylpropion2-(diethylamino)propiophenone"
  },
  {
    "page_number": 22,
    "bbox": [
      215.11,
      423.31,
      437.97,
      450.74
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "99 Alprazolam8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine"
  },
  {
    "page_number": 22,
    "bbox": [
      212.11,
      455.95,
      402.0,
      465.02
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "100 Allobarbital5,5-diallylbarbituric acid"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      469.15,
      424.41,
      478.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "101 Aminorex2-amino-5-phenyl-2-oxazoline"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      482.35,
      404.12,
      491.42
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "102 Barbital5,5-diethylbarbituric acid"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      495.55,
      401.84,
      513.74
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "103 BenzphetamineN-benzyl-N,-dimethylphenethylamine"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      517.87,
      439.41,
      545.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "104 Bromazepam7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4- benzodiazepin-2-one"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      549.55,
      380.85,
      567.74
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "105 Butobarbitone5-butyl-5-(Butobarbital)ethylbarbituricacid"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      575.95,
      416.12,
      603.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "106 Brotizolam2-bromo-4-(o- chlorophenyl) -9-methyl- 6H-thieno[3,2-f]-s-triazolo[4,3- a][1,4]diazepine"
  },
  {
    "page_number": 22,
    "bbox": [
      212.23,
      608.47,
      438.69,
      675.02
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "107 Camazepam7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl- 2H-1,4-benzodiazepin-2-onedimethylcarbamate (ester)108 Chlordiazepoxide7-chloro-2-(methylamino)-5-phenyl-3H-1,4- benzodiazepine-4-oxide"
  },
  {
    "page_number": 23,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "23Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 23,
    "bbox": [
      144.93,
      203.35,
      366.09,
      232.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "109 Clobazam7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine- 2,4(3H,5H)-dione"
  },
  {
    "page_number": 23,
    "bbox": [
      144.93,
      237.07,
      372.81,
      255.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "110 Clonazepam5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4- benzodiazepin-2-one"
  },
  {
    "page_number": 23,
    "bbox": [
      144.93,
      260.83,
      371.27,
      289.7
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "111 Clorazepate7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4- benzodiazepine-3-carboxylic acid"
  },
  {
    "page_number": 23,
    "bbox": [
      144.93,
      298.51,
      366.09,
      327.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "112 Clotiazepam5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H- thieno[2,3-e]-1,4-diazepin- 2-one"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      333.31,
      371.38,
      403.7
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "113 Cloxazolam10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro- oxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one114 Delorazepam7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4- benzodiazepin-2-one"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      408.55,
      369.1,
      437.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "115 Diazepam7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4- benzodiazepin-2-one"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      442.27,
      371.25,
      461.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "116 Ethchlorvynol1-chloro-3-ethyl-1-penten-4-yn-3-ol"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      466.03,
      364.56,
      475.1
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "117 Ethinamate1-ethynylcyclohexanolcarbamate"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      479.95,
      379.54,
      498.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "118 Estazolam8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      507.79,
      372.09,
      611.9
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "119 Ethyl loflazepateethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo- 1H-1,4-benzodiazepine-3- carboxylate120 N-ethylamphetamineN-ethyl--methylphenethylamine121 Etizolam4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4] triazolo[4,3a][1,4] diazepine122 Fludiazepam7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H- 1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 23,
    "bbox": [
      144.81,
      620.71,
      361.53,
      671.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "123 Flurazepam7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)- 1,3-dihydro-2H-1,4-benzodiazepin-2-one124 FencamfaminN-ethyl-3-phenyl-2-norbornanamine"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "24Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      203.11,
      419.84,
      221.78
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "125 Fenproporex()-3-[(-methylphenylethyl)amino]propionitrile"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      230.35,
      452.11,
      258.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "126 Flualprazolam8-Chloro-6-(2-fluoro-phenyl)-1-methyl-4h- benzo[f][1,2,4]triazolo[4,3-a][1,4] diazepime"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      264.19,
      436.4,
      292.46
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "127 Halazepam7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)- 2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      297.91,
      425.11,
      326.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "128 Haloxazolam10-bromo-11b-(o-fluorophenyl)-2,3,7,11b- tetrahydrooxazolo[3,2-d][1,4]benzodiazepin- 6(5H)-one"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      331.75,
      425.11,
      400.46
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "129 Ketazolam11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione130 Lefetamine (SPA)()-N,N-dimethyl-1,2-diphenylethylamine"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      408.91,
      434.95,
      487.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "131 Loprazolam6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one132 Lorazepam7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H- 1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      495.79,
      437.97,
      545.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "133 Lormetazepam7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1- methyl-2H-1,4- benzodiazepin-2-one134 Mazindol5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      549.79,
      399.57,
      568.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "135 Meprobamate2-methyl-2-propyl-1,3-propanedioldicarbamate"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      572.95,
      389.98,
      591.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "136 Methylphenobarbital5-ethyl-1-methyl-5-phenylbarbituric acid"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      596.11,
      406.4,
      614.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "137 Methyprylon3,3-diethyl-5-methyl-2,4-piperidine-dione"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      619.39,
      436.41,
      638.06
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "138 Medazepam7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4- benzodiazepine"
  },
  {
    "page_number": 24,
    "bbox": [
      212.11,
      642.55,
      395.13,
      661.22
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "139 MefenorexN-(3-chloropropyl)--methylphenethylamine"
  },
  {
    "page_number": 25,
    "bbox": [
      186.09,
      166.97,
      384.81,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "25Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      203.11,
      358.3,
      231.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "140 Midazolam8-chloro-6-(o-fluorophenyl)-1-methyl-4H- imidazo[1,5-a][1,4]benzodiazepine"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      235.99,
      365.87,
      254.66
    ],
    "fonts": [
      "Symbol",
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "141 Mesocarb3-(-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      259.15,
      363.58,
      287.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "142 Nimetazepam1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      291.91,
      368.15,
      310.58
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "143 Nitrazepam1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      315.19,
      360.59,
      333.86
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "144 Nordazepam7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      338.35,
      366.56,
      366.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "145 Oxazepam7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      375.19,
      369.56,
      424.58
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "146 Oxazolam10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin- 6(5H)-one147 Phendimetrazine(+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      429.19,
      357.58,
      438.26
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "148 Phenobarbital5-ethyl-5-phenylbarbituric acid"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      452.35,
      349.31,
      461.42
    ],
    "fonts": [
      "Symbol",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "149 Phentermine,-dimethylphenethylamine"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      465.91,
      383.86,
      474.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "150 Pipradrol1,1-diphenyl-1-(2-piperidyl) methanol"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      479.59,
      368.14,
      507.86
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "151 Pinazepam7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H- 1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      516.31,
      356.13,
      565.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "152 Prazepam7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5- phenyl-2H-1,4-benzodiazepin-2- one153 Pyrovalerone4-methyl-2-(1-pyrrolidinyl) valerophenone"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      570.31,
      362.86,
      588.98
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "154 Pemoline2-amino-5-phenyl-2-oxazolin-4-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      593.59,
      349.3,
      621.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "155 Phenazepam7-bromo-5-(2-chlorophenyl)(Fenazepam)-1,3-dihydro-2H-1,4- benzodiazepin-2-one"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      626.35,
      365.18,
      635.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "156 Secbutabarbital5-sec-butyl-5-ethylbarbituric acid"
  },
  {
    "page_number": 25,
    "bbox": [
      143.85,
      639.91,
      366.56,
      668.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "157 Temazepam7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl- 2H-1,4-benzodiazepin-2-one"
  },
  {
    "page_number": 26,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "26Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 26,
    "bbox": [
      211.15,
      202.99,
      434.71,
      261.14
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      7.797435283660889,
      8.0
    ],
    "text": "158 Tetrazepam7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1- methyl-2H-1,4-benzodiazepin-2- one159 Triazolam8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s- triazolo[4,3- a][1,4]benzodiazepine"
  },
  {
    "page_number": 26,
    "bbox": [
      211.15,
      265.39,
      441.45,
      283.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "160 Vinylbital5-(1-methylbutyl)-5-vinylbarbituricacid"
  },
  {
    "page_number": 26,
    "bbox": [
      211.15,
      288.19,
      430.88,
      306.74
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "161 ZolpidemN,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide"
  },
  {
    "page_number": 26,
    "bbox": [
      223.15,
      318.65,
      451.16,
      348.26
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0,
      9.949873924255371
    ],
    "text": "1. The isomers, unless specifically excepted, of the drugs in thisSection whenever the existence of such isomers is possiblewithin the specific chemical designation."
  },
  {
    "page_number": 26,
    "bbox": [
      223.87,
      358.03,
      451.17,
      385.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "2. The esters and ethers, unless appearing in another part, of thedrugs in this Section whenever the existence of such esters orethers is possible."
  },
  {
    "page_number": 26,
    "bbox": [
      223.87,
      395.59,
      451.15,
      423.5
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "3. The salts of the dangerous drugs mentioned in this Section,including the salts of the isomers, whenever the formation ofsuch salts is possible."
  },
  {
    "page_number": 26,
    "bbox": [
      223.87,
      433.15,
      451.17,
      461.06
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "4. Any substance, that are substantially similar to the parentsubstances listed in this Section, which typically exhibitinghigh abuse potential."
  },
  {
    "page_number": 26,
    "bbox": [
      223.87,
      470.83,
      451.2,
      508.1
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "5. Any chemical analogue with modification in any of the atomof the parent substance listed in this Section by any atom orspecific group of atoms (functional group), which typicallyexhibiting high abuse potential."
  },
  {
    "page_number": 26,
    "bbox": [
      223.87,
      517.75,
      451.19,
      545.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      7.949842929840088,
      8.0
    ],
    "text": "6. Substances, preparations or mixtures containing any proportionof drug/drugs in this Section and isomers, esters and salts asspecified in the paragraphs 1, 2, 3, 4 and 5 above."
  },
  {
    "page_number": 26,
    "bbox": [
      314.71,
      555.43,
      347.71,
      564.5
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "SECTION 3"
  },
  {
    "page_number": 26,
    "bbox": [
      211.15,
      574.15,
      451.13,
      602.06
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "The groups of substances, including any salt or sterioisomeric formof such substances and any preparation, mixture or a productcontaining such substances as indicated below:"
  },
  {
    "page_number": 26,
    "bbox": [
      222.43,
      611.83,
      451.18,
      639.62
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "1. Amphetamine analogues, other than listed in the above Section2, in which the 1-amino-2- phenylethane nucleus carries anyof the following substituent, either alone or in combination:"
  },
  {
    "page_number": 26,
    "bbox": [
      242.71,
      649.39,
      451.15,
      667.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) 1 or 2 alkyl substituents, each with up to 6 carbon atoms,attached to the nitrogen atom;"
  },
  {
    "page_number": 27,
    "bbox": [
      187.05,
      166.97,
      385.89,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "27Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      203.11,
      385.96,
      231.26
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) 1 or 2 methyl substituents or an ethyl substituent,attached to the carbon atom adjacent to the nitrogenatom;"
  },
  {
    "page_number": 27,
    "bbox": [
      178.05,
      241.27,
      385.8,
      259.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) a hydroxy substituent attached to the carbon atomadjacent to the benzene ring;"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      269.71,
      385.94,
      326.3
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) any combination of up to 5 alkyl substituent and/oralkoxy substituent and/or alkylamino substituent and/or alkylthio substituent (each with up to 6 carbon atoms,including cyclic substituent) and/or halogen substituentand/or nitro substituent and/or amino substituent,attached to the benzene ring."
  },
  {
    "page_number": 27,
    "bbox": [
      157.05,
      336.19,
      385.93,
      402.26
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "2. Pethidine analogues, in which any substance (not being listedin above Section 1) structurally derived from pethidine(4-phenylpiperidine nucleus) by modification in any of theatom by any atom or specific group of atoms (functional group)or stereoisomeric form of any such substance, any preparationor product containing any such substance and thereof, any ofthe following ways:-"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      412.27,
      385.9,
      440.3
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) by replacement of the 1-methyl group by an acyl, alkylwhether or not unsaturated, benzyl or phenethyl group,whether or not further substituted;"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      450.19,
      385.92,
      478.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) by substitution in the piperidine ring with alkyl oralkenyl groups or with a propano bridge, whether ornot further substituted;"
  },
  {
    "page_number": 27,
    "bbox": [
      178.05,
      488.23,
      385.79,
      506.78
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) by substitution in the 4-phenyl ring with alkyl, alkoxy,aryloxy, halogen or haloalkyl groups;"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      516.67,
      385.93,
      535.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) by replacement of the 4-ethoxycarbonyl by any otheralkoxycarbonyl or any alkoxyalkyl or acyloxy group;"
  },
  {
    "page_number": 27,
    "bbox": [
      178.05,
      545.23,
      377.51,
      554.3
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(e) by formation of an N-oxide or of a quaternary base."
  },
  {
    "page_number": 27,
    "bbox": [
      156.09,
      564.19,
      385.9,
      601.82
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "3.Phencyclidine analogues, any substance other than listed inthe above Section 2, being chemical substances withthe 1-alkylamino-1-arylcyclohexane (arylcycloalkylamines)structure, with any combination of the followings:-"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      611.71,
      385.91,
      639.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) the alkylamino substituent is 1-piperidinyl,1-pyrrolidinyl, 4-morpholinyl, or any other substituentwith up to 6 carbon atoms in the alkyl portion;"
  },
  {
    "page_number": 27,
    "bbox": [
      177.33,
      649.99,
      385.9,
      668.66
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) the aryl substituent is phenyl, thienyl, pyridinyl, orpyrrolidinyl;"
  },
  {
    "page_number": 28,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "28Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 28,
    "bbox": [
      244.39,
      203.35,
      452.26,
      242.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) the aryl substituent, carries any combination of up to 5alkyl substituents and/or alkoxy substituent (each withup to 6 carbon atoms, including cyclic substituents)and/or halogen substituents;"
  },
  {
    "page_number": 28,
    "bbox": [
      243.67,
      252.91,
      452.14,
      281.78
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) any related substances, including any salt orstereoisomeric form of such substances, and anypreparation or product containing such substances."
  },
  {
    "page_number": 28,
    "bbox": [
      223.39,
      292.51,
      452.24,
      331.22
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "4. Fentanyl analogues, any substance other than listed in aboveSection 1, in which the N-[1-(2- phenethyl)-4-piperidyl]anilinenucleus has additional substituents, either alone or incombination or by any modification attached as follows:-"
  },
  {
    "page_number": 28,
    "bbox": [
      243.67,
      341.95,
      452.23,
      370.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) by replacement of the phenyl portion of the phenethylgroup by any heteromonocycle whether or not furthersubstituted in the heterocycle;"
  },
  {
    "page_number": 28,
    "bbox": [
      243.67,
      381.55,
      452.14,
      410.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) by substitution in the phenethyl group with alkyl,alkenyl, alkoxy, hydroxy, halogen, haloalkyl, aminoor nitro groups;"
  },
  {
    "page_number": 28,
    "bbox": [
      244.39,
      421.15,
      452.12,
      440.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) by substitution in the piperidine ring with alkyl or alkenylgroups;"
  },
  {
    "page_number": 28,
    "bbox": [
      243.67,
      450.91,
      452.14,
      469.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) by substitution in the aniline ring with alkyl, alkoxy,alkylenedioxy, halogen or haloalkyl groups;"
  },
  {
    "page_number": 28,
    "bbox": [
      244.39,
      480.55,
      452.12,
      509.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(e) by substitution at the 4-position of the piperidine ringwith anyalkoxycarbonyl or alkoxyalkyl or acyloxygroup;"
  },
  {
    "page_number": 28,
    "bbox": [
      245.95,
      520.15,
      452.23,
      539.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(f) by replacement of the N-propionyl group by anotheracyl group; or"
  },
  {
    "page_number": 28,
    "bbox": [
      243.67,
      549.91,
      452.13,
      578.78
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(g) any substances (other than a substance listed in Section1), structurally derived from (1-Methyl- 4-piperidyl)-N-phenylformamide by any substitution and thereof."
  },
  {
    "page_number": 28,
    "bbox": [
      223.39,
      599.35,
      452.25,
      638.18
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "5. Methaqualone analogues, any substance other than listed inthe above Section 2, in which the 3- arylquinazolin-4-onenucleus has additional substituents, either alone or incombination, attached as follows:"
  },
  {
    "page_number": 28,
    "bbox": [
      243.67,
      648.91,
      452.25,
      667.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) an alkyl substituent, with up to 6 carbon atoms, attachedat the 2 position;"
  },
  {
    "page_number": 29,
    "bbox": [
      187.05,
      166.97,
      385.89,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "29Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 29,
    "bbox": [
      179.37,
      203.47,
      387.83,
      242.9
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) any combination of up to 5 alkyl substituents and/oralkoxy substituents (each with up to 6 carbon atoms,including cyclic substituents) and/or halogensubstituents, attached to each of the aryl rings."
  },
  {
    "page_number": 29,
    "bbox": [
      159.09,
      253.99,
      387.93,
      333.74
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "6. Tryptamines analogues, which any substance (other than asubstance listed in the above Section 2 or serotonin) structurallyderived from 2-(1Hindol-3-yl) ethanamine (tryptamine) orfrom a ring- hydroxy by modification in any of the atom byany atom or specific group of atoms (functional group),including any ether, salt or stereoisomeric form of any suchsubstance, any preparation or product containing any suchsubstance and thereof, such as-"
  },
  {
    "page_number": 29,
    "bbox": [
      179.37,
      344.95,
      387.83,
      384.26
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) by substitution at the nitrogen atom of the side chain toany extent with alkyl or alkenyl substituents or byinclusion of the nitrogen atom of the side chain (and noother atoms of the side chain) in acyclic structure;"
  },
  {
    "page_number": 29,
    "bbox": [
      179.37,
      395.47,
      387.83,
      424.7
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) by substitution at the carbon atom adjacent to thenitrogen atom of the side chain with alkyl or alkenylsubstituents;"
  },
  {
    "page_number": 29,
    "bbox": [
      180.09,
      435.79,
      387.84,
      465.02
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) by substitution in the 6-membered ring to any extentwith alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy,or halide substituents;"
  },
  {
    "page_number": 29,
    "bbox": [
      179.37,
      476.23,
      387.85,
      495.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) by substitution at the 2-position of the tryptamine ringsystem with an alkyl substituent."
  },
  {
    "page_number": 29,
    "bbox": [
      159.09,
      506.47,
      327.09,
      515.54
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "7. Synthetic Cathinones and their analogues."
  },
  {
    "page_number": 29,
    "bbox": [
      171.81,
      526.75,
      387.96,
      596.42
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Any substance, (other than a substance listed in the aboveSection 2 or bupropion) that is structurally derived from2- amino-1-phenylpropan-1-one by modification in any ofthe atom by any substitution by an atom or a specific group ofatoms (functional group) or substituent including any salt orstereoisomeric form thereof, and any preparation or productcontaining thereof."
  },
  {
    "page_number": 29,
    "bbox": [
      159.09,
      607.51,
      294.09,
      616.58
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "8. Aminodanes and their analogues."
  },
  {
    "page_number": 29,
    "bbox": [
      171.81,
      627.67,
      387.99,
      667.1
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Any aminodane (other than listed in the above Sections) andany substance, including any salt or stereoisomeric form ofsuch substances, and any preparation or product containingsuch substances."
  },
  {
    "page_number": 30,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "30Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 30,
    "bbox": [
      222.43,
      203.23,
      374.7,
      212.3
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "9. Phenethylamines and their analogues."
  },
  {
    "page_number": 30,
    "bbox": [
      235.15,
      222.67,
      451.2,
      309.26
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Any phenethylamine substance (other than a substance listedin the above Section 2), including any type of positional isomerin the phenyl ring by modification in any of the atom by anysubstitution by an atom or a specific group of atoms (functionalgroup), substituted substances such as the 2C series, ringsubstituted amphetamines such as the D series, anybenzodifurans or its substituent and any others substancethereof, including any salt or stereoisomeric form thereof, andany preparation or product containing thereof."
  },
  {
    "page_number": 30,
    "bbox": [
      217.87,
      319.63,
      451.18,
      367.46
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "10. Any substance (not being bupropion, cathinone, diethylpropion,pyrovalerone or not being listed for the time being specified inabove Sections) structurally derived from 2amino1phenyl1 propanone by modification in any of the following ways,that is to say-"
  },
  {
    "page_number": 30,
    "bbox": [
      242.71,
      377.83,
      451.18,
      415.94
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) by substitution in the phenyl ring to any extent withalkyl, alkoxy, alkylenedioxy, haloalkyl or halidesubstituents, whether or not further substituted in thephenyl ring by one or more other univalent substituents;"
  },
  {
    "page_number": 30,
    "bbox": [
      242.71,
      426.31,
      451.14,
      435.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) by substitution at the 3position with an alkyl substituent;"
  },
  {
    "page_number": 30,
    "bbox": [
      243.43,
      445.75,
      451.18,
      474.14
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) by substitution at the nitrogen atom with alkyl or dialkylgroups, or by inclusion of the nitrogen atom in a cyclicstructure."
  },
  {
    "page_number": 30,
    "bbox": [
      217.87,
      484.51,
      451.18,
      561.5
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "11. Any substance (other than a substance listed in above Sections)structurally derived from 2 aminopropan1one bysubstitution at the 1-position with any monocyclic or fused-polycyclic ring system or not being listed for the time beingspecified in above Sections or not being a phenyl ring oralkylenedioxyphenyl ring system), whether or not thesubstance is further modified in any of the following ways,that is to say-"
  },
  {
    "page_number": 30,
    "bbox": [
      242.71,
      571.75,
      451.19,
      609.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) by substitution in the ring system to any extent withalkyl, alkoxy, alkylenedioxy haloalkyl or halidesubstituents, whether or not further substituted in thering system by one or more other univalent substituents;"
  },
  {
    "page_number": 30,
    "bbox": [
      242.71,
      620.35,
      451.14,
      629.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) by substitution at the 3position with an alkyl substituent;"
  },
  {
    "page_number": 30,
    "bbox": [
      243.43,
      639.67,
      451.16,
      668.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) by substitution at the 2-amino nitrogen atom with alkylor dialkyl groups, or by inclusion of the 2-aminonitrogen atom in a cyclic structure."
  },
  {
    "page_number": 31,
    "bbox": [
      187.05,
      166.97,
      385.89,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "31Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 31,
    "bbox": [
      153.57,
      203.23,
      386.9,
      251.06
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "12. Any substance (not being listed in above Sections or not beingpipradrol) structurally derived from piperidine, pyrrolidine,azepane, morpholine or pyridine by substitution at a ring carbonatom with a diphenylmethyl group, whether or not the substanceis further modified in any of the following ways, that is to say-"
  },
  {
    "page_number": 31,
    "bbox": [
      178.29,
      261.43,
      386.86,
      280.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) by substitution in any of the phenyl rings to any extentwith alkyl, alkoxy, haloalkyl or halide groups;"
  },
  {
    "page_number": 31,
    "bbox": [
      178.29,
      290.47,
      386.88,
      309.26
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) by substitution at the methyl carbon atom with an alkyl,hydroxyalkyl or hydroxy group;"
  },
  {
    "page_number": 31,
    "bbox": [
      179.13,
      319.63,
      386.87,
      338.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) by substitution at the ring nitrogen atom with an alkyl,alkenyl, haloalkyl or hydroxyalkyl group."
  },
  {
    "page_number": 31,
    "bbox": [
      153.57,
      348.67,
      386.87,
      386.9
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "13. Any substance falls into the category of SyntheticCannabinoids (other than listed in above Section 2), any saltor stereoisomeric form of such substances, and any preparationor product containing such substances:"
  },
  {
    "page_number": 31,
    "bbox": [
      178.29,
      397.27,
      386.88,
      474.14
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) Any substance other than listed in above Section 2,containing a 3-(1-naphthylmethyl)indole structure withsubstitution at the nitrogen atom of the indole ring byan atom or any specific group of atoms (functionalgroup), and any derivatives of the above substancesincluding any salt or stereoisomeric form of the abovesubstances or derivatives, and any preparation or productcontaining the above substances or derivatives;"
  },
  {
    "page_number": 31,
    "bbox": [
      178.29,
      484.51,
      386.92,
      571.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) Any substance other than listed in above Section 2,containing a 3-(1-naphthoyl)pyrrole structure withsubstitution at the nitrogen atom of the pyrrole ring byan atom or any specific group of atoms (functionalgroup), and any derivatives of the above substancescontaining functional groups, including any salt orstereoisomeric form of the above substances orderivatives, and any preparation or product containingthe above substances or derivative;"
  },
  {
    "page_number": 31,
    "bbox": [
      179.13,
      581.47,
      386.89,
      668.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) Any substance other than listed in above Section 2,containing a naphthylideneindene structure with anysubstitution at any position of the indene ring by anatom or any specific group of atoms (functional group),and any derivatives of the above substances containinghydroxy and/or carboxylic acid groups, including anysalt or stereoisomeric form of the above substances orderivatives, and any preparation or product containingthe above substances or derivatives;"
  },
  {
    "page_number": 32,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "32Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      203.35,
      451.21,
      291.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) Any substance other than listed in above Section 2,containing a 2-(3-hydroxycyclohexyl)phenol structurewith substitution at any position of the phenolic ring byan atom or any specific group of atoms (functionalgroup), and any derivatives of the above substancescontaining hydroxy and/or carboxylic acid groups,including any salt or stereoisomeric form of the abovesubstances or derivatives, and any preparation or productcontaining the above substances or derivatives."
  },
  {
    "page_number": 32,
    "bbox": [
      217.87,
      302.35,
      435.43,
      311.42
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "14. The analogues gamma-Hydroxybutyrate (GHB) and"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      322.15,
      407.75,
      331.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) the esters, ethers, and amides of GHB; and"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      341.95,
      451.17,
      360.98
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) all substances from which GHB can be derived, including(without limitation)"
  },
  {
    "page_number": 32,
    "bbox": [
      268.87,
      371.71,
      337.87,
      380.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(i) 1,4-butanediol;"
  },
  {
    "page_number": 32,
    "bbox": [
      266.71,
      391.51,
      378.44,
      400.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(ii) gamma-aminobutyric acid;"
  },
  {
    "page_number": 32,
    "bbox": [
      264.43,
      411.31,
      363.44,
      420.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(iii) gamma-butyrolactone;"
  },
  {
    "page_number": 32,
    "bbox": [
      264.43,
      431.11,
      411.4,
      440.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(iv) gamma-hydroxybutyraldehyde; and"
  },
  {
    "page_number": 32,
    "bbox": [
      243.43,
      450.91,
      451.2,
      479.78
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) the salts of GHB (including sodium oxybate) and thesalts of any substance referred to in paragraph (a) orparagraph (b); and"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      490.51,
      451.18,
      519.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) any substance, preparation, or mixture containing anyproportion of GHB or any substance referred to in anyof paragraphs (a) to (c)."
  },
  {
    "page_number": 32,
    "bbox": [
      217.87,
      530.11,
      428.72,
      539.18
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "15. Plant based substances causing a psychoactive effect"
  },
  {
    "page_number": 32,
    "bbox": [
      235.15,
      549.91,
      451.18,
      568.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Any part of the plant other than listed in above Sections 1 and2, any extract or preparation thereof of the following plants:"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      579.55,
      331.87,
      588.62
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(a) Khat (Catha edulis);"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      599.35,
      365.59,
      608.42
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(b) Kratom (Mitragyna speciosa);"
  },
  {
    "page_number": 32,
    "bbox": [
      243.43,
      619.15,
      352.15,
      628.22
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(c) Salvia (Salvia divinorum);"
  },
  {
    "page_number": 32,
    "bbox": [
      242.71,
      638.95,
      367.15,
      648.02
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(d) Chacruna (Psychiotria viridis);"
  },
  {
    "page_number": 32,
    "bbox": [
      243.43,
      658.75,
      389.71,
      667.82
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(e) Mimosa hostilis (Mimosa tenuiflora);"
  },
  {
    "page_number": 33,
    "bbox": [
      187.05,
      166.97,
      385.89,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "33Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 33,
    "bbox": [
      178.65,
      203.11,
      355.65,
      212.18
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(f) Hawaiian Baby Woodrose (Argyreia nervosa);"
  },
  {
    "page_number": 33,
    "bbox": [
      176.37,
      222.31,
      292.53,
      231.38
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(g) Iboga (Tabernanthe iboga),"
  },
  {
    "page_number": 33,
    "bbox": [
      192.81,
      241.51,
      384.87,
      288.98
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "or any other plant containing any dangerous drug or asubstance substantially similar to dangerous drugs or ansubstituted analogue of a dangerous drug listed in aboveSections 1 and 2, which typically exhibiting high abusepotential.."
  },
  {
    "page_number": 33,
    "bbox": [
      161.37,
      299.11,
      384.85,
      317.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "(2)by the repeal of Part III of that Schedule and the substitutiontherefor of the following Part:-"
  },
  {
    "page_number": 33,
    "bbox": [
      244.29,
      327.91,
      384.83,
      346.58
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "PART III (section 54A)"
  },
  {
    "page_number": 33,
    "bbox": [
      247.65,
      356.71,
      282.08,
      365.78
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "PART III"
  },
  {
    "page_number": 33,
    "bbox": [
      144.81,
      376.15,
      321.69,
      407.54
    ],
    "fonts": [
      "Times-BoldItalic"
    ],
    "sizes": [
      8.0
    ],
    "text": "Column IColumn IIColumn IIINature ofPure QuantitiesPenaltyOffences"
  },
  {
    "page_number": 33,
    "bbox": [
      145.29,
      418.75,
      217.53,
      461.42
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "Traffics,Opiumpossess,imports orexports"
  },
  {
    "page_number": 33,
    "bbox": [
      155.37,
      466.15,
      238.3,
      485.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-1 kilogrammeor above"
  },
  {
    "page_number": 33,
    "bbox": [
      155.37,
      496.87,
      245.85,
      526.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-500 grammes toless than1 kilogramme"
  },
  {
    "page_number": 33,
    "bbox": [
      155.37,
      537.31,
      241.29,
      566.54
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-50 grammes toless than500 grammes"
  },
  {
    "page_number": 33,
    "bbox": [
      155.37,
      607.99,
      241.29,
      637.94
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-10 grammes toless than50 grammes"
  },
  {
    "page_number": 33,
    "bbox": [
      251.85,
      605.11,
      381.84,
      671.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than One HundredThousand Rupees and not exceedingTwo Hundred Thousand Rupees andimprisonment of either description fora period not less than five years andnot exceeding ten years or to bothsuch fine and imprisonment."
  },
  {
    "page_number": 33,
    "bbox": [
      252.93,
      533.11,
      381.95,
      599.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than Two HundredThousand Rupees and not exceedingFive Hundred Thousand Rupees andimprisonment of either description fora period not less than ten years andnot exceeding fifteen years or to bothsuch fine and imprisonment."
  },
  {
    "page_number": 33,
    "bbox": [
      251.85,
      466.51,
      350.14,
      475.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Death or life imprisonment."
  },
  {
    "page_number": 33,
    "bbox": [
      251.85,
      493.51,
      320.13,
      502.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Life imprisonment."
  },
  {
    "page_number": 34,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "34Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 34,
    "bbox": [
      214.63,
      203.11,
      291.56,
      221.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-Less than10 grammes"
  },
  {
    "page_number": 34,
    "bbox": [
      248.11,
      270.31,
      436.39,
      279.38
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "Morphine, Cocaine, Heroin and Methamphetamine"
  },
  {
    "page_number": 34,
    "bbox": [
      214.63,
      289.51,
      409.64,
      308.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-5 grammes or Death or life imprisonment. above"
  },
  {
    "page_number": 34,
    "bbox": [
      248.11,
      318.31,
      296.12,
      346.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "3 grammes toless than5 grammes"
  },
  {
    "page_number": 34,
    "bbox": [
      248.11,
      395.11,
      296.12,
      423.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "2 grammes toless than3 grammes"
  },
  {
    "page_number": 34,
    "bbox": [
      248.11,
      471.91,
      287.11,
      490.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Less than2 grammes"
  },
  {
    "page_number": 34,
    "bbox": [
      248.11,
      548.71,
      282.54,
      557.78
    ],
    "fonts": [
      "Times-Bold"
    ],
    "sizes": [
      8.0
    ],
    "text": "Cannabis"
  },
  {
    "page_number": 34,
    "bbox": [
      248.11,
      567.91,
      304.39,
      586.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "100 kilogrammesor above"
  },
  {
    "page_number": 34,
    "bbox": [
      312.19,
      318.91,
      444.21,
      385.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than Two HundredThousand Rupees and not exceedingFive Hundred Thousand Rupees andimprisonment of either description fora period not less than ten years and notexceeding twenty years or to both suchfine and imprisonment."
  },
  {
    "page_number": 34,
    "bbox": [
      312.19,
      395.11,
      444.21,
      461.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than One HundredThousand Rupees and not exceedingTwo Hundred Thousand Rupees andimprisonment of either description fora period not less than seven years andnot exceeding ten years or to both suchfine and imprisonment."
  },
  {
    "page_number": 34,
    "bbox": [
      312.19,
      470.95,
      444.21,
      544.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than Twenty FiveThousand Rupees and not exceedingFifty Thousand Rupees andimprisonment of either description fora period not less than three years andnot exceeding five years or to bothsuch fine and imprisonment."
  },
  {
    "page_number": 34,
    "bbox": [
      312.19,
      567.19,
      444.21,
      633.86
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than Two HundredThousand Rupees and not exceedingFive Hundred Thousand Rupees andimprisonment of either description fora period not less than ten years and notexceeding fifteen years or to both suchfine and imprisonment."
  },
  {
    "page_number": 34,
    "bbox": [
      214.63,
      316.51,
      229.63,
      325.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 34,
    "bbox": [
      214.63,
      394.51,
      229.63,
      403.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 34,
    "bbox": [
      214.63,
      472.51,
      229.63,
      481.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 34,
    "bbox": [
      214.63,
      568.51,
      229.63,
      577.58
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 34,
    "bbox": [
      312.19,
      203.11,
      444.21,
      260.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not exceeding One HundredThousand Rupees and imprisonmentof either description for a period notless than two years and not exceedingfive years or to both such fine andimprisonment."
  },
  {
    "page_number": 35,
    "bbox": [
      187.05,
      166.97,
      385.89,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "35Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 35,
    "bbox": [
      192.81,
      203.11,
      248.26,
      231.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "5 kilogrammesto less than 100kilogrammes"
  },
  {
    "page_number": 35,
    "bbox": [
      192.81,
      279.91,
      252.1,
      308.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "1 kilogramme toless than5 kilogrammes"
  },
  {
    "page_number": 35,
    "bbox": [
      192.81,
      356.71,
      242.26,
      375.38
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Less than1 kilogramme"
  },
  {
    "page_number": 35,
    "bbox": [
      144.81,
      445.37,
      384.85,
      492.71
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "7. For the avoidance of doubt, it is hereby declared thatthe provisions of section 6 shall not apply in respect of anoffence which was committed prior to the date of cominginto operation of this Act."
  },
  {
    "page_number": 35,
    "bbox": [
      144.81,
      505.37,
      384.95,
      528.71
    ],
    "fonts": [
      "Times-Bold",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "8. In the event of any inconsistency between the Sinhalaand Tamil texts of this Act, the Sinhala text shall prevail."
  },
  {
    "page_number": 35,
    "bbox": [
      398.85,
      446.59,
      446.86,
      465.26
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Avoidance ofdoubt"
  },
  {
    "page_number": 35,
    "bbox": [
      398.85,
      506.59,
      449.86,
      544.46
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Sinhala text toprevail in caseofinconsistency"
  },
  {
    "page_number": 35,
    "bbox": [
      252.81,
      203.11,
      383.87,
      269.78
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than One HundredThousand Rupees and not exceedingTwo Hundred Thousand Rupees andimprisonment of either description fora period not less than five years andnot exceeding ten years or to bothsuch fine and imprisonment."
  },
  {
    "page_number": 35,
    "bbox": [
      252.81,
      280.99,
      383.87,
      347.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than Fifty ThousandRupees and not exceeding OneHundred Thousand Rupees andimprisonment of either description fora period not less than two years andnot exceeding five years or to bothsuch fine and imprisonment."
  },
  {
    "page_number": 35,
    "bbox": [
      252.81,
      352.99,
      383.87,
      419.66
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "Fine not less than Twenty ThousandRupees and not exceeding FiftyThousand Rupees and imprisonmentof either description for a period notless than one year and not exceedingtwo years or to both such fine andimprisonment."
  },
  {
    "page_number": 35,
    "bbox": [
      154.29,
      203.11,
      169.29,
      212.18
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 35,
    "bbox": [
      154.29,
      280.15,
      169.29,
      289.22
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 35,
    "bbox": [
      154.29,
      357.55,
      169.29,
      366.62
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      8.0
    ],
    "text": "-do-"
  },
  {
    "page_number": 36,
    "bbox": [
      212.11,
      166.97,
      410.8,
      190.79
    ],
    "fonts": [
      "Times-Italic",
      "Times-Roman"
    ],
    "sizes": [
      10.0
    ],
    "text": "36Poisons, Opium and Dangerous Drugs(Amendment) Act, No. 41 of 2022"
  },
  {
    "page_number": 36,
    "bbox": [
      141.67,
      631.15,
      449.95,
      649.82
    ],
    "fonts": [
      "Times-Roman"
    ],
    "sizes": [
      5.599999904632568,
      8.0
    ],
    "text": "English Acts of the Parliament can be purchased at the PRAKASHANA PIYASA, DEPARTMENT OFGOVERNMENT PRINTING, NO. 118, DR. DANISTER DE SILVA MAWATHA, COLOMBO 8."
  }
]